CN1267530A - 一种治疗肺结核的中药 - Google Patents

一种治疗肺结核的中药 Download PDF

Info

Publication number
CN1267530A
CN1267530A CN 98115357 CN98115357A CN1267530A CN 1267530 A CN1267530 A CN 1267530A CN 98115357 CN98115357 CN 98115357 CN 98115357 A CN98115357 A CN 98115357A CN 1267530 A CN1267530 A CN 1267530A
Authority
CN
China
Prior art keywords
radix
pulmonary tuberculosis
chinese medicine
blood
nourishing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN 98115357
Other languages
English (en)
Inventor
王春秀
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN 98115357 priority Critical patent/CN1267530A/zh
Publication of CN1267530A publication Critical patent/CN1267530A/zh
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

本发明为一种治疗肺结核的纯中药制剂,它是由当归、血竭、三七、没药、白及、红花、百合等15味中药经混合加工后制成的散剂,具有调补气血,滋阴降火,润肺止咳,活血化瘀的功能。诸药并用共奏固本培元之效,使肺结核患者虚火得降,潮热得解,肺气可清,络血不溢,痰化咳愈,达到治疗目的。经多例临床验证本发明疗效确切、药效迅速、疗程短、治愈率高。

Description

一种治疗肺结核的中药
本发明属于医药领域,涉及一种治疗肺结核的中药。
目前,国内外治疗肺结核的西药主要有异烟肼、利福平、链霉素、乙胺丁醇、氨硫脲,对氨水杨酸钠及吡嗪酰胺等;中药治疗肺结核(肺痨)的配方也很多,如百合固金汤加减、秦艽鳖甲散加减、月华丸加减、保真汤加减等。上述中西药物对治疗肺结核都能起到积极作用,治愈了大批肺结核患者。但疗程较长,按我国长期使用的标准治疗方案,疗程为18-24个月,最短为1年;即使采用短程治疗方案,3药或4药并用,疗程仍需9个月以上。因疗程较长,易产生抗药性,药物副作用较大,并有一定的复发率,使患者不易配合。
本发明的目的是提供一种对肺结核病能标本兼治、疗效确切、疗程较短、治愈率高、不易复发的无毒副作用的中药配方。
本发明的药物配方(按重量比):当归10-12%、血竭8-10%,三七6-8%、白及3-5%、没药6-8%、续断6-8%、红花6-8%、地鳖虫6-8%、骨碎补6-8%、百合6-8%、陈皮8-10%、贝母3-5%、桔梗3-5%、丹皮3-5%、地骨皮6-8%,将以上药物混合后制成散剂,亦可制成丸剂、胶囊或片剂。
本发明通过调补气血,滋阴降火、润肺止咳、活血化瘀之法,共奏固本培元之效。方中当归补血养血、养阴润燥、再配以血竭、红花、三七、地鳖虫、骨碎补、没药等多味活血化瘀之品,兼收止痛止血之功,使瘀血祛,新血生,肺有所养。丹皮、地骨皮清热凉血而退骨蒸,加之白及敛肺生肌,百合、贝母润肺养阴化痰,桔梗宣肺止咳,诸药并用虚火得降、潮热得解、肺气可清、络血不溢,痰化咳愈。再以理气健脾、止咳化痰之陈皮,滋补肝肾、通脉活血之续断佐之,培元而固本,使肺疾愈而无复发之虑。本发明可以通治各型肺结核。本发明系家传多代秘方,治愈肺结核(肺痨)患者多人,疗效显著确切,疗程短。
本发明的具体实施例如下:取当归50g、血竭40g、三七30g、白及20g、没药30g、续断30g、红花30g、地鳖虫30g、骨碎补30g、百合30g、陈皮40g、  贝母20g、桔梗20g、丹皮20g、地骨皮30g混在一起制成散剂,日服二次,每服3-5g。

Claims (1)

  1. 一种治疗肺结核的中药,其特征在于所用药物配方(按重量比计):当归10-12%,血竭8-10%、三七6-8%、白及3-5%、没药6-8%、续断6-8%、红花6-8%、地鳖虫6-8%、骨碎补6-8%、百合6-8%、陈皮8-10%、贝母3-5%、桔梗3-5%、丹皮3-5%、地骨皮6-8%,将以上药物混合后制成散剂,亦可制成丸剂、胶囊或片剂。
CN 98115357 1998-06-29 1998-06-29 一种治疗肺结核的中药 Pending CN1267530A (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 98115357 CN1267530A (zh) 1998-06-29 1998-06-29 一种治疗肺结核的中药

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 98115357 CN1267530A (zh) 1998-06-29 1998-06-29 一种治疗肺结核的中药

Publications (1)

Publication Number Publication Date
CN1267530A true CN1267530A (zh) 2000-09-27

Family

ID=5224532

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 98115357 Pending CN1267530A (zh) 1998-06-29 1998-06-29 一种治疗肺结核的中药

Country Status (1)

Country Link
CN (1) CN1267530A (zh)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104189473A (zh) * 2014-09-19 2014-12-10 强红枫 一种治疗结核病的药物组合物及其制备方法

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104189473A (zh) * 2014-09-19 2014-12-10 强红枫 一种治疗结核病的药物组合物及其制备方法

Similar Documents

Publication Publication Date Title
Jia et al. Common traditional Chinese medicinal herbs for dysmenorrhea
CN101129578A (zh) 乳香褥疮散
CN100493585C (zh) 一种治疗慢性盆腔炎、月经不调疾病的纯中药
CN100388944C (zh) 一种治疗牙痛的中药散剂
CN101306177B (zh) 一种治疗小儿腹泻的中药及其制备方法
CN1267530A (zh) 一种治疗肺结核的中药
CN1072858A (zh) 一种治疗结肠炎药物的制做方法
CN102580142A (zh) 一种用于骨科手术术后愈合的中药敷药及制备方法
CN1186056C (zh) 骨质增生治疗药物
Law et al. Use of Chinese medicine in the prevention and treatment of COVID-19 in China and Asia
CN1333026A (zh) 一种治疗乳腺增生的药物
CN101439127A (zh) 一种治疗骨折的药剂
Li Traditional Chinese medicine for primary liver cancer
CN1268368A (zh) 治疗腰椎间盘突出的中药制剂
CN1234402C (zh) 一种治疗骨折的药剂
CN116211992B (zh) 一种用于治疗溃疡性结肠炎诱发抑郁样行为的中药组合物
CN102430026A (zh) 祛斑药物
US20220175865A1 (en) Traditional chinese medicine compound composition with anti-anxiety effect and preparation method and applications thereof
CN102085350A (zh) 一种治疗关节炎的药物及其制备方法
CN101199636A (zh) 一种治疗白癜风的药物
CN1141953C (zh) 一种治疗骨髓炎的中药胶囊及其制备工艺
CN101757355A (zh) 治疗不孕症的中药制剂
CN100444832C (zh) 一种治疗咽炎的药物
CN1279988A (zh) 一种治疗肿瘤的药
CN1061855C (zh) 抗风湿复方药剂

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication